BRUNELLI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 28.980
EU - Europa 24.912
AS - Asia 16.749
SA - Sud America 2.558
Continente sconosciuto - Info sul continente non disponibili 961
AF - Africa 578
OC - Oceania 51
Totale 74.789
Nazione #
US - Stati Uniti d'America 27.975
RU - Federazione Russa 9.388
SG - Singapore 6.378
CN - Cina 4.963
GB - Regno Unito 4.655
IT - Italia 3.525
BR - Brasile 1.975
VN - Vietnam 1.517
HK - Hong Kong 1.514
DE - Germania 1.443
SE - Svezia 1.428
FR - Francia 1.120
IE - Irlanda 1.111
FI - Finlandia 851
CA - Canada 624
KR - Corea 546
BD - Bangladesh 383
IN - India 284
NL - Olanda 270
UA - Ucraina 252
JP - Giappone 239
AR - Argentina 194
TR - Turchia 179
MX - Messico 170
ES - Italia 152
PL - Polonia 148
NG - Nigeria 126
BE - Belgio 118
ZA - Sudafrica 109
ID - Indonesia 108
IQ - Iraq 106
CO - Colombia 94
EC - Ecuador 89
AT - Austria 80
LT - Lituania 75
PK - Pakistan 67
VE - Venezuela 67
TG - Togo 62
MA - Marocco 55
BJ - Benin 52
SA - Arabia Saudita 51
CL - Cile 50
UZ - Uzbekistan 44
AU - Australia 43
JM - Giamaica 43
CZ - Repubblica Ceca 41
PH - Filippine 41
PY - Paraguay 37
CR - Costa Rica 34
MY - Malesia 33
AE - Emirati Arabi Uniti 30
TN - Tunisia 29
EG - Egitto 27
JO - Giordania 27
KE - Kenya 27
IR - Iran 26
AZ - Azerbaigian 25
PT - Portogallo 22
HN - Honduras 21
LV - Lettonia 21
CH - Svizzera 20
DZ - Algeria 20
AL - Albania 19
IL - Israele 19
KZ - Kazakistan 19
PE - Perù 18
RS - Serbia 17
NP - Nepal 16
RO - Romania 16
DK - Danimarca 15
GR - Grecia 15
UY - Uruguay 15
BO - Bolivia 14
DO - Repubblica Dominicana 14
EE - Estonia 14
PA - Panama 14
PS - Palestinian Territory 14
TT - Trinidad e Tobago 14
BG - Bulgaria 13
CI - Costa d'Avorio 12
SN - Senegal 12
HU - Ungheria 11
NI - Nicaragua 11
TH - Thailandia 11
KG - Kirghizistan 10
LB - Libano 10
PR - Porto Rico 10
AM - Armenia 9
ET - Etiopia 9
GT - Guatemala 9
HR - Croazia 9
LK - Sri Lanka 9
NO - Norvegia 9
BY - Bielorussia 8
CY - Cipro 8
EU - Europa 8
MD - Moldavia 8
OM - Oman 8
SV - El Salvador 8
TW - Taiwan 8
Totale 73.667
Città #
Ashburn 3.764
Southend 3.696
Singapore 3.423
Moscow 3.153
San Jose 2.718
Chandler 2.463
Dallas 2.338
Hong Kong 1.487
Jacksonville 1.333
Dublin 1.097
Woodbridge 1.071
Beijing 1.018
Council Bluffs 1.015
Ann Arbor 947
Verona 917
The Dalles 754
New York 747
Los Angeles 616
Houston 528
Munich 482
Ho Chi Minh City 472
Lawrence 368
Princeton 366
Wilmington 345
Jinan 331
Hanoi 315
Helsinki 308
Santa Clara 295
Nanjing 247
São Paulo 244
Milan 238
Buffalo 233
Shenyang 229
Rome 225
Tokyo 219
Montréal 195
Columbus 179
Mcallen 179
Tianjin 175
Hebei 174
Orem 169
Redondo Beach 169
Montreal 165
London 160
Turku 145
Sindelfingen 133
Dearborn 131
Frankfurt am Main 128
Zhengzhou 126
Denver 122
Warsaw 120
Seattle 119
Redmond 118
Abuja 115
Seoul 112
Brussels 111
Brooklyn 107
Chicago 107
Ningbo 105
Changsha 104
Guangzhou 104
Bologna 103
Atlanta 102
Toronto 101
Boardman 96
Phoenix 95
Taizhou 93
Stockholm 92
Chennai 91
Haikou 87
Amsterdam 84
Nanchang 79
Mexico City 76
Redwood City 74
Hangzhou 72
San Francisco 71
Johannesburg 70
Taiyuan 70
Jiaxing 66
Lancaster 65
Rio de Janeiro 64
Haiphong 61
Lomé 61
Poplar 61
Da Nang 59
Boston 57
Dong Ket 57
Washington 57
Manchester 55
Norwalk 55
Las Vegas 53
Cotonou 52
Madrid 52
Volga 47
Belo Horizonte 45
Detroit 45
Nuremberg 45
Vienna 45
Jakarta 44
Baghdad 43
Totale 44.219
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 924
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 682
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 394
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 347
Una complessa valutazione della vitalità delle fratture in ambito forense 336
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 330
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 279
Schwannoma del rene 272
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 271
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 266
Combining interphase and metaphase analyses in the differential diagnosis among renal cell neoplasms with distal nephron differentiation 265
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 265
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 263
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 263
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 260
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 257
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 255
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 255
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 251
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 242
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 242
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 239
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 239
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 238
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 237
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 235
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 234
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 232
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 232
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 231
CD10 is expressed in a subset of chromophobe renal cell carcinomas 229
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 229
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 229
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 228
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 227
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 227
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 226
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 226
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 225
Adenocarcinoma of the paraurethral glands: a case report 225
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 224
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 224
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 223
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 222
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 222
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 221
Chondroid syringoma with extensive ossification 221
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 220
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 219
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 217
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 216
Liver Metastases From Renal Oncocytoma With Vascular Extension 214
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 214
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 213
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 213
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 212
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 212
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 211
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 210
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 210
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 210
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 210
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 210
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 210
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 209
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 209
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 208
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 208
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 208
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 208
Donor-Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes 207
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 206
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 206
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 206
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 205
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 205
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 205
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 204
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 204
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 204
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 204
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 202
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 202
Diagnostic concordance between whole slide imaging and conventional light microscopy in cytopathology: A systematic review 202
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 201
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 201
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 201
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 201
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 201
[Diagnostic and prognostic markers in renal tumors] 199
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 199
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 199
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 199
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 199
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 198
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 198
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 198
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory Analysis 197
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 197
Totale 23.882
Categoria #
all - tutte 257.456
article - articoli 235.103
book - libri 0
conference - conferenze 21.776
curatela - curatele 0
other - altro 577
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 514.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.942 0 0 0 338 149 130 49 204 93 84 231 664
2022/20237.013 458 768 612 1.182 603 1.732 72 480 762 72 162 110
2023/20244.061 171 299 325 444 481 669 198 245 66 279 634 250
2024/202510.090 506 543 548 1.647 427 350 576 448 1.426 680 979 1.960
2025/202632.245 2.050 1.605 2.348 5.564 8.268 2.112 2.683 1.635 2.687 1.899 561 833
2026/20274.526 486 829 1.144 2.067 0 0 0 0 0 0 0 0
Totale 74.789